FDA Guidance Update on Peptide API Manufacturing — Key Takeaways

The FDA has released updated guidance on peptide API manufacturing under 21 CFR Part 211, with new requirements for impurity profiling and process validation. Hyxtide’s QA team has reviewed the guidance and confirmed full compliance. We summarize the key changes and their impact on peptide manufacturers.